Reply to ABarnett.
I am paraphrasing in some places to save space.
I asked if I was right in thinking that the “vast library” you offered to send Geoff was not limited to the 24 items I could find about LDN and MS on Web of Knowledge.
You replied that I should google OGF and that you had over 100 papers regarding OGF and endorphins. (I’m assuming that this part of your post was to do with the above question because it is not terribly clear.)
I searched the academic database Web of Knowledge last time for articles regarding OGF and the immune system as well as LDN and MS, but I have now searched again using your recommended terms. OGF AND endorphins returned 21 items; “opioid growth factor” AND endorphins returned 29 items. Searching within these for “multiple sclerosis” returned 0 items.
I asked if some empirical data been published that support the role of met enkephalin in treating demyelination?
You did not respond.
You cited a paper by Zagon et al. It is a study of mice. I asked if there were any human data.
You did not respond.
I asked what you meant “effectively” in the statement that available drugs do not manage MS effectively.
You did not respond.
I asked what happened in response to your statement that Avonex accelerated your MS.
You did not respond.
I asked you to supply supporting information for your statement that the Avonex trial found that “the wrong DNA, it [Avonex] is bad news.”
You did not respond.
I asked you to retract the statement, “Tysabri killed a lot of people in the trial!” because it is wrong.
You have not retracted the statement. Instead you replied that you believed the number to be 39 or 49. It was not. I ask you again to retract the statement.
Late addition to this reply: You have just now stated that you stand by your statement despite revising the number from 39-49 to 3. I welcome the use of the words “I seem to remember” rather than presenting beliefs as facts and I suggest that you familiarise yourself with the correct data before you brandish such inflammatory and potentially scary statements again. Also, I find utterly bewildering and incredibly insensitive that you can call this type of thing “trivial”. Amongst other things, you claim that Avonex is “bad news” if you have the wrong DNA, but do not explain yourself and claim that lots of people died in the Tysabri trial. Put yourself in the situation of someone already on Avonex or Tysabri who reads this thread. For their sake, and anyone else who may be affected by the information on this forum, it is essential that that information is objective, accurate and robust.
I asked you how you know if LDN is helping you if you are still progressing and not having relapses, but are diagnosed as SPMS.
You replied that you don’t know, but that you haven’t had any relapses since starting on LDN. I appreciate your honesty, but am still puzzled – were you RRMS when you started on LDN or perhaps SPMS with recent relapses?
I now turn to the rest of your reply. I have a few questions/points.
You said, “Progresion is about existing nerve damage which for me was made too bad by the avonex reaction in the first place.”
You have an unusual understanding of progression versus my own knowledge and the information presented on reputable websites such as the multiple sclerosis research blogspot. Are you suggesting that progression does not involve new damage? How would a reaction to Avonex add to nerve damage? You suggest that I talk to a neuro to understand it. I suggest that if you present information as fact, you should be able to explain it yourself.
You say, “there is no medical or clinical reason to deny it [LDN] to me, so I should be able to get that prescription on the NHS.”
I’m wondering what you mean by no medical or clinical reason?
What are the implications for the NHS, if such a policy was to be implemented?